---
title: "Clinical characteristics, hospital interventions, and outcomes of SARS‑CoV‑2 in Nepal: age as a st"
id: "medrxiv-3-clinico-epidemiological-characteristics-hospital-care-interventions-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-clinico-epidemiological-characteristics-hospital-care-interventions-and"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1?rss=1"
published_at: "2026-09-10T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Clinical characteristics, hospital interventions, and outcomes of SARS‑CoV‑2 in Nepal: age as a st
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-clinico-epidemiological-characteristics-hospital-care-interventions-and
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1?rss=1)
- **Published At:** 2026-09-10T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Prospective observational study of 348 adults with laboratory-confirmed **SARS-CoV-2** admitted to a tertiary teaching hospital in Nepal between March 30, 2022 and June 30, 2023 and followed to discharge or in‑hospital death. - Overall in-hospital **survival** was 79.6% (277/348); 20.4% (71/348) died. - Older adults made up 41.1% of the cohort. The most common comorbidities were hypertension (29.3%) and diabetes mellitus (23.0%). - Predominant presenting symptoms were fever (81.0%), cough (75.9%), and dyspnea (48.0%). - Statistical methods included Chi-square/Fisher’s exact tests, multivariable binary logistic regression, and mediation analysis using Hayes’ PROCESS Macro v4.2, Model 4, with 5,000 bias-corrected bootstrap samples. - In multivariable analysis, **age** group and dyspnea were independently associated with hospital survival. - In unadjusted analyses, **steroid therapy**, **oxygen therapy**, and **respiratory support** were significantly associated with survival; after adjustment, steroid therapy–survival relationship showed a partial statistical mediation by **age** (indirect effect = −0.1371; 95% bootstrap CI: −0.3053 to −0.0154), while the direct effect remained significant (c′ = −2.8670; p = 0.0049). - No significant age‑mediated indirect effects were found for oxygen therapy or respiratory support. - Authors caution the mediation result should be interpreted as statistical rather than causal because **age** precedes treatment exposure. - Ethical approvals were obtained from three committees; written informed consent was secured and data are available in the manuscript/supporting files.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Ol5MZhhHct8z7tOutt6Yz5oqrGnk0DySkXaIXVVdlj0-1789092037.4587865-1.2.1.1-XVW_fy9uisdm1QK2gsLerwqAuzgye0i7e6itqvE1bbHLPqwFjAj2tWrrSpcXQTh3) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Clinico-Epidemiological Characteristics, Hospital Care Interventions, and Clinical Outcomes of Patients with SARS-CoV-2 in Nepal: The Mediating Role of Age [ View ORCID Profile](http://orcid.org/0009-0000-4408-198X)Mamata Sharma Neupane, Hafizah Che Hassan, [ View ORCID Profile](http://orcid.org/0000-0002-1471-8318)Surendra Uranw, [ View ORCID Profile](http://orcid.org/0000-0002-1241-8119)Raj Kumar Mehta doi: https://doi.org/10.64898/2026.09.08.26362589 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Mamata Sharma Neupane 1 Chitwan Medical College; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mamata%2BSharma%2BNeupane%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Neupane%20MS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMamata%2BSharma%2BNeupane%2B) * [ORCID record for Mamata Sharma Neupane](http://orcid.org/0009-0000-4408-198X "Open in new tab") * For correspondence: sharma.mamata@cmc.edu.np Hafizah Che Hassan 2 Lincoln University College; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hafizah%2B%2BChe%2BHassan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hassan%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHafizah%2B%2BChe%2BHassan%2B) Surendra Uranw 3 BP Koirala Institute of Health Sciences * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Surendra%2BUranw%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Uranw%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASurendra%2BUranw%2B) * [ORCID record for Surendra Uranw](http://orcid.org/0000-0002-1471-8318 "Open in new tab") Raj Kumar Mehta 1 Chitwan Medical College; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Raj%2B%2BKumar%2BMehta%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mehta%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARaj%2B%2BKumar%2BMehta%2B) * [ORCID record for Raj Kumar Mehta](http://orcid.org/0000-0002-1241-8119 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1297079/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1297079/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1297079/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1297079/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1297079/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Coronavirus disease 2019 (COVID-19) outcomes among hospitalized patients are influenced by demographic characteristics, clinical presentation, and requirements for hospital-based care. Age is an important determinant of COVID-19 outcomes; however, its statistical role in the relationships between hospital-care interventions and survival has received limited attention in resource-constrained settings. This prospective observational analytical study assessed clinico-epidemiological characteristics, hospital-care interventions, clinical outcomes, and the mediating role of patient age group among adults hospitalized with SARS-CoV-2 infection in Nepal. A total of 348 adults with laboratory-confirmed SARS-CoV-2 infection were consecutively recruited at a tertiary care teaching hospital from March 30, 2022 to June 30, 2023 and followed until discharge or in-hospital death. Associations with survival were examined using Chi-square/Fisher’s exact tests and multivariable binary logistic regression. Mediation analyses were performed using Hayes’ PROCESS Macro version 4.2, Model 4, with 5,000 bias-corrected bootstrap samples. Of 348 participants, 277 (79.6%) survived and 71 (20.4%) died. Older adults constituted 41.1% of participants. Hypertension (29.3%) and diabetes mellitus (23.0%) were the most common comorbidities, while fever (81.0%), cough (75.9%), and dyspnea (48.0%) were the predominant symptoms. Age group and dyspnea remained independently associated with hospital survival in multivariable analysis. Steroid therapy, oxygen therapy, and respiratory support were significantly associated with survival in unadjusted analyses. Age group partially statistically mediated the steroid therapy–survival relationship (indirect effect = −0.1371; 95% bootstrap CI: −0.3053 to −0.0154), while the direct effect remained significant (c′ = −2.8670; p = 0.0049). No significant age-mediated indirect effects were observed for oxygen therapy or respiratory support. These findings highlight the importance of age and respiratory presentation in hospital outcomes and suggest age-related heterogeneity in the steroid therapy–survival relationship. The mediation finding should be interpreted as statistical rather than causal because age precedes treatment exposure. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval for the study was obtained from the Research Ethics Committee of Lincoln University College, Malaysia (LUC/INT/113/2022 7 February 2022), the Nepal Health Research Council, Kathmandu, Nepal (NHRC/77/2022 PhD 23 March 2022), and the Institutional Review Committee of Chitwan Medical College Teaching Hospital, Nepal (CMC-IRC/078/079-149 30 March 2022). The subsequent amendment incorporating the mediation objective and analysis using Hayes' PROCESS Macro was reviewed and approved by the Research Ethics Committee of Lincoln University College (LUC/REC/INT/211/2023 17 August 2023). The amendment did not alter participant recruitment, clinical management, data collection procedures, or participant risk. Written informed consent was obtained from participants before enrolment. When patients lacked decision-making capacity because of critical illness, unconsciousness, mechanical ventilation, or another clinical condition, written informed consent was obtained from their Legally Authorized Representative. Participation was voluntary, and refusal to participate did not affect clinical care. Participant information was handled confidentially, and only de-identified data were used for statistical analysis. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data are in the manuscript and/or supporting information files. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.04.25.26351736v2 "Individualized cortical gradient and network topology reveal symptom-linked disruptions and neurobiological subtypes in schizophrenia")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.04.26362259v1 "Cohort-Defined Low Skeletal Muscle Mass and Functional Dependency After Critical Illness: A 12-Month Longitudinal Study") Posted September 10, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/10/2026.09.08.26362589.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.08.26362589v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/10/2026.09.08.26362589.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Clinico-Epidemiological Characteristics, Hospital Care Interventions, and Clinical Outcomes of Patients with SARS-CoV-2 in Nepal: The Mediating Role of Age Mamata Sharma Neupane, Hafizah Che Hassan, Surendra Uranw, Raj Kumar Mehta medRxiv 2026.09.08.26362589; doi: https://doi.org/10.64898/2026.09.08.26362589 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.08.26362589v1%26text%3DClinico-Epidemiological%2520Characteristics%252C%2520Hospital%2520Care%2520Interventions%252C%2520and%2520Clinical%2520Outcomes%2520of%2520Patients%2520with%2520SARS-CoV-2%2520in%2520Nepal%253A%2520The%2520Mediating%2520Role%2520of%2520Age "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.08.26362589v1%26t%3DClinico-Epidemiological%2520Characteristics%252C%2520Hospital%2520Care%2520Interventions%252C%2520and%2520Clinical%2520Outcomes%2520of%2520Patients%2520with%2520SARS-CoV-2%2520in%2520Nepal%253A%2520The%2520Mediating%2520Role%2520of%2520Age "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.08.26362589v1%26title%3DClinico-Epidemiological%2520Characteristics%252C%2520Hospital%2520Care%2520Interventions%252C%2520and%2520Clinical%2520Outcomes%2520of%2520Patients%2520with%2520SARS-CoV-2%2520in%2520Nepal%253A%2520The%2520Mediating%2520Role%2520of%2520Age%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.08.26362589v1%26title%3DClinico-Epidemiological%2520Characteristics%252C%2520Hospital%2520Care%2520Interventions%252C%2520and%2520Clinical%2520Outcomes%2520of%2520Patients%2520with%2520SARS-CoV-2%2520in%2520Nepal%253A%2520The%2520Mediating%2520Role%2520of%2520Age "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.08.26362589) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.08.26362589v1&count=horizontal&via=&text=Clinico-Epidemiological%20Characteristics%2C%20Hospital%20Care%20Interventions%2C%20and%20Clinical%20Outcomes%20of%20Patients%20with%20SARS-CoV-2%20in%20Nepal%3A%20The%20Mediating%20Role%20of%20Age&counturl=www.medrxiv.org/content/10.64898/2026.09.08.26362589v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (616) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (898) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (330) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4794) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (478) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (414) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (647) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1624) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15908) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1200) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7027) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (732) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1063) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5025) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1431) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1753) * [Hematology](https://www.medrxiv.org/collection/hematology) (584) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1341) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16274) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1167) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (667) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (153) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (722) * [Neurology](https://www.medrxiv.org/collection/neurology) (7245) * [Nursing](https://www.medrxiv.org/collection/nursing) (366) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1078) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1237) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1002) * [Oncology](https://www.medrxiv.org/collection/oncology) (3595) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1047) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (396) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (451) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (469) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (706) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1792) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (735) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (762) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5872) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9736) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2408) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1446) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1246) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (639) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (770) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (578) * [Surgery](https://www.medrxiv.org/collection/surgery) (774) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (304) * [Urology](https://www.medrxiv.org/collection/urology) (289) Evaluation/discussion of t
## Related Clinical Research

- [Undercoding of Long COVID and Predicting U09.9 from All of Us EHR Summaries](https://medichelpline.com/clinical-feed/medrxiv-8-long-covid-undercoding-and-prediction-from-releasable-electronic-health-record.md)
- [Measles deaths: why the ‘died with’ vs. ‘died of’ debate misses the broader issue](https://medichelpline.com/clinical-feed/stat-news-4-opinion-the-died-with-vs-died-of-measles-discussion-misses-something-very.md)
- [Using a Genetic Inflammatory Index and Prakriti Stratification to Predict Inflammaging Risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-17-predicting-susceptibility-to-inflammaging-using-a-genetic-inflammatory-index.md)
- [Make Exercise a Prescription: ACC Urges Routine Use for Heart Health](https://medichelpline.com/clinical-feed/medical-news-today-0-exercise-should-be-a-prescription-for-a-healthier-heart-experts-say.md)
- [Rising national stroke incidence and deaths in Uganda, 2016–2028 forecasts](https://medichelpline.com/clinical-feed/plos-one-5-rising-stroke-burden-in-uganda-a-national-time-series-analysis-and-forecasts.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.